MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
DMAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

DiaMedica Therapeutics (DMAC) Ownership - Who owns DiaMedica Therapeutics?

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
35
Web
https://www.diamedica.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
292.32M
P/E Ratio
N/A
Total Cash
51.33M
Projected Growth
N/A
Total Debt
212K
Revenue
N/A
Risk (Beta)
2.12
Dividend Yield
N/A
Total Cash/Share
0.95
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
DMAC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for DMAC
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
35
Web
https://www.diamedica.com